Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cancer Prev Res (Phila). 2016 Dec 13;10(2):108–115. doi: 10.1158/1940-6207.CAPR-16-0219

Table 4.

Microsatellite instability low (MSI-L) endometrial adenocarcinomas with associated immunohistochemistry (IHC), family history and germline test results

Study Number MSI Result IHC Result Age at Diagnosis FDR with LATs1 Germline Testing Result Clinical Interpretation
1009 MSI-L Intact Staining 59 Daughter: precancerous colon polyp at age 48 No MSH6 mutation detected Presumed sporadic
1021 MSI-L Intact Staining 59 No No MSH6 mutation detected Presumed sporadic
1066 MSI-L Loss of MLH1/PMS2 MLH1 methylation present 62 No Not performed Presumed sporadic
1108 MSI-L Intact MLH1, MSH2, MSH6 staining2 53 No MSH6
VUS3
Uncertain
1115 MSI-L Intact Staining 52 No Insurance denied testing Uncertain, likely sporadic
1129 MSI-L Intact Staining 54 No Not offered genetic testing4 Presumed sporadic
1

FDR, First Degree Relative; LAT, Lynch Syndrome Associated Tumors (colorectal, stomach, endometrial ovarian, biliary, sebaceous adenomas)

2

IHC for PMS2 unsuccessful; both tumor and internal positive control lacked staining

3

VUS, variant of unknown significance

4

Endometrial cancer was believed to be secondary to the concurrent ovarian granulosa cell tumor